Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma

NCT01752205 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Carcinoma

Interventions

DRUG: Paclitaxel
DRUG: Erlotinib
RADIATION: Radiation therapy

Sponsor

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences